Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04129138

Patient and Caregiver Attitudes and Beliefs Regarding Prescription of Intranasal Naloxone Spray for Opioid Overdose

A Survey of High Risk Patient and Caregiver Attitudes and Beliefs Regarding the Prescription of Intranasal Naloxone Spray for Opioid Overdose

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
182 (actual)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This trial studies the attitudes and beliefs of high risk patients and caregivers regarding the prescription of intranasal naloxone spray for opioid overdose. Knowledge regarding high risk patients' and caregivers' beliefs and attitudes regarding co-prescription of naloxone spray with opioids may help to identify barriers to prescribing and helping tailor the education to better meet the needs of patients and caregivers.

Detailed description

PRIMARY OBJECTIVE: I. To determine the proportion of high risk patients who perceive receiving a prescription of intranasal naloxone to be beneficial for them. SECONDARY OBJECTIVES: I. To determine the proportion of caregivers who perceive receiving a prescription of intranasal naloxone to be beneficial for the patient. II. To determine the association between high risk patients' and their caregivers' characteristics (this includes cut-annoyed-guilty-eye \[CAGE\], screener and opioid assessment for patients with pain \[SOAPP\], age, gender, ethnicity, education, employment status, presence of caregiver, cancer type, cancer stage, reason for Narcan prescription, health insurance, and setting of Narcan prescription) and their perception that a prescription for intranasal naloxone is beneficial for patients. EXPLORATORY OBJECTIVE: I. To conduct an exploratory analysis of high risk patients' and caregivers' attitudes and beliefs regarding prescription of intranasal naloxone spray. OUTLINE: Participants complete a survey over 30 minutes.

Conditions

Interventions

TypeNameDescription
OTHERSurvey AdministrationComplete survey

Timeline

Start date
2020-07-18
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2019-10-16
Last updated
2026-04-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04129138. Inclusion in this directory is not an endorsement.